CCL2 and Miyoshi myopathy: Another relevant molecule is represented by CCL2, a chemokine with the ability to recruit TAM, trigger their polarization towards an immunosuppressive M2 subtype and stimulate TAM to express the monocyte chemoattractant protein-1-induced protein (MCPIP1), which could protect MM cells from bortezomib-mediated apoptosis [121].